The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Weil, Gotshal & Manges LLP

767 5TH AVENUE, NEW YORK, NY 10153, USA
Tel:
Work +1 212 310 8000
Fax:
Fax +1 212 310 8007
Web:
www.weil.com

Michael Epstein

Tel:
Work +1 212 310 8432
Email:
Weil, Gotshal & Manges LLP

Career

Michael Epstein, Head of Weil’s Technology & IP Transactions Practice, is a recognized expert in intellectual property and technology law. His practice involves transactions, litigation and counseling in all areas of IP and technology. His transactional work includes intellectual property acquisitions, technology transfer and licensing arrangements, outsourcing, joint ventures and other targeted alliances. His litigation experience includes misappropriation of trade secrets, breach of non-compete agreements, trademark infringement and false advertising. He is the author of 'Epstein on Intellectual Property' and co-editor of "Drafting License Agreements."

Education

Lehigh University (BA, 1975); New York University School of Law (JD, 1979).


United States: Industry focus

Healthcare: life sciences

Within: Healthcare: life sciences

The ‘thorough’ and ‘strong’ group at Weil, Gotshal & Manges LLP advises on the full gamut of corporate and litigation matters for clients in the life sciences arena, including antitrust and IP issues. Silicon Valley-based co-head Edward Reines successfully represented Stanford University in an appeal arising from an inventorship dispute with the Chinese University of Hong Kong regarding a revolutionary test for Down’s syndrome. ‘Extremely organized’ patent litigation partner Elizabeth Weiswasser, who has a ‘solid understanding of scientific issues’, has been representing Acorda Therapeutics in the company’s appeal to the Federal Circuit regarding a patent infringement judgment involving its Ampyra drug. IP partner Jeffrey Osterman and private equity partner Christopher Machera led advice to National Surgical Hospitals on its $760m acquisition by Surgery Partners. The group is also headed by Michael Epstein. Named partners are based in New York unless otherwise stated.

[back to top]

United States: Intellectual property

Patents: licensing

Within: Leading lawyers

Michael Epstein - Weil, Gotshal & Manges LLP

Within: Patents: licensing

Weil, Gotshal & Manges LLP’s key area of expertise is technology transactions, but the team is also adept at assisting life sciences clients. On the corporate transactional side, the group covers licences in relation to mergers and acquisitions, joint ventures, and strategic alliances, while the non-transactional practice includes research and development agreements as well as e-commerce contracts, outsourcing transactions and professional service agreements. The firm is present in New York, where practice head Michael Epstein, Jeffrey Osterman and Charan Sandhu are based, and on the West Coast; here Karen Ballack is the main contact in Silicon Valley after John Brockland left for Hogan Lovells US LLP. Despite Brockland’s departure the group handles a large number of high-profile matters, such as advising Sanofi on the licensing aspects of its $25bn agreement with Boehringer Ingelheim through which the client swapped its animal health business Merial for Boehringer’s consumer healthcare business. General Electric, Signet Jewelers and Eli Lilly are other key clients.

[back to top]

United States: Media, technology and telecoms

Technology: transactions

Within: Leading lawyers

Michael Epstein - Weil, Gotshal & Manges LLP

Within: Technology: transactions

Weil, Gotshal & Manges LLP is regularly engaged in sophisticated transactions, including technology acquisitions and dispositions, joint ventures and strategic alliances, as well as research and development (R&D) collaborations, licensing agreements, outsourcing transactions and e-commerce agreements. New York-based global technology and IP transactions head Michael Epstein acted for inVentiv Health in the technology and IP aspects of its $4.6bn merger with INC Research Holdings; Charan Sandhu advised the transaction committee of the board of directors of Reynolds American (Reynolds) on the technology and IP aspects of its $60.6bn sale to British American Tobacco (BAT) of the 57.8% of Reynolds’ stock that BAT did not already own; and Jeffrey Osterman advised French multinational pharmaceutical company Sanofi on the technology and IP aspects of the $25bn exchange of its animal health business for the consumer healthcare business of Boehringer Ingelheim. Silicon Valley-based Karen Ballack is also highly rated. Richard Climan, John Brockland, Max Scott, Keith Flaum, Jane Ross, and Christopher Moore joined Hogan Lovells US LLP.

[back to top]


Back to index

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to
  • THE VAT E-COMMERCE PACKAGE

    A. INTRODUCTION   The VAT E-commerce Package adopted by the Council on the 5th of December 2017 includes several changes that will be gradually implemented, some changes will be effective as from the 1st of January 2019 and the rest as from the 1st of January 2021.
  • Doing business in Ukraine: turning point for the currency control in Ukraine

    One of the most hotly discussed topics in 2019 is currency control liberalization in Ukraine.The currency control liberalization was one of Ukraine’s priorities under the EU-Ukraine Association Agreement. At the beginning of 2019 the National Bank of Ukraine (hereinafter the “NBU”) approved and promulgated all long-awaited regulations, serving as the basis for a new liberal system of foreign currency control. The new currency control system will be launched on 7 February 2019, the same day as the Law of Ukraine  On Currency and Exchange Transactions  becomes applicable. The changes are aimed at deregulation, facilitating cross-border transactions with foreign currency and expanding the list of available foreign currency transactions.
  • New Long Term Residency Visas

    After much media coverage, Cabinet Decision 56 of 2018 (the Decision ) has been gazetted which introduces new long term residency visas to, amongst others, four categories of persons in the UAE. 
  • Significant Changes to Civil Procedure Code

    Significant changes to Federal Law No 11 of 1992 (the Civil Procedure Code ) will soon be coming into effect. These changes are introduced through regulations (the Regulations ) issued under the Civil Procedure Code and will come into effect on 16 February 2019.
  • Merger Clearance Matters

    The United Arab Emirates (the UAE ) promulgated legislation to specifically address the regulation of competition (being Federal Law 4 of 2012, or the Competition Law ) several years ago but until recently, it has been the case that the requisite implementing regulations and processes were not in place. This is no longer the case. Not only have the much anticipated implementing regulations been issued, the UAE Ministry of Economy (the Ministry ) (being the regulator in charge of administering the UAE competition regime) has now formed the required committee and issued the anticipated guidance and forms to allow concerned parties to make merger clearance submissions to the Ministry where required to do so pursuant to the Competition Law. 
  • Korean TR, Finally and Officially Coming Soon

    Korean TR, Finally and Officially Coming Soon
  • Key Changes to Korean Labor Standards Act in 2019

    Key Changes to Korean Labor Standards Act in 2019
  • fwp helps find a new mega arena location

    fwp helps find a new mega arena location
  • Direction of Financial Regulatory Environment of Korea in 2019: Legislation Supporting Financial Inn

    Direction of Financial Regulatory Environment of Korea in 2019: Legislation Supporting Financial Innovation and Reform of Supervisory System
  • WORLD SHIPPING LAW FORUM, ATHENS JANUARY 2019

    Stelios Americanos & Co LLC, participated in WORLD SHIPPING LAW FORUM in Athens that has taken place on the 25th January 2019. The conference took place at N.J.V. Athens Plaza.